Search Results 681-690 of 17424 for alopecia
Ongoing toxicity from previous anticancer therapy that has not resolved to baseline levels or to Grade 1 or less, except for alopecia,; Participants with ...
Learn more about how damaged hair follicles become infected. This condition may clear up on its own, but severe infections can cause scarring or hair loss.
The overall objective is to develop a clinical data registry that can be used to facilitate research with the ultimate goal of reducing the morbidity and/or ...
... alopecia, weight changes and grade I or II lymphopenia. Myelosuppressive chemotherapy: must not have received within 3 weeks of entry onto this study (6 ...
With the exception of alopecia, and CTCAE Grade 2 neuropathy, any unresolved toxicities from prior therapy > Grade 1 at the time of starting study treatment.
... alopecia or Grade 2 peripheral neuropathy prior to randomization. A washout period of at least 21 days is required between last chemotherapy dose and ...
At Mayo Clinic, you have access to the latest advances and proven innovations for diagnosing and treating cancer. Not all services are provided at all ...
All toxicities attributed to prior anti-cancer therapy other than nephropathy, neuropathy, hearing loss, alopecia and fatigue must have resolved to Grade 1 ...
Abnormal visual development early in life can cause reduced vision in one eye, which often wanders inward or outward.
Toxic effects of prior anti-cancer therapy considered as chronic, such as chemotherapy-induced fatigue, alopecia, or anorexia of ≤ Grade 2, where no more ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.